We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PPH

News List

Organon Acquires Alydia Health americanpharmaceuticalreview
June 18, 2021
Organon, a global women’s healthcare company, announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or ...
Sun Pharma, Ferring Pharmaceuticals sign licensing agreement to launch CARITEC in India expresspharma
June 03, 2021
Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialise a ...
Vectura and Monash University Support Development of Inhaled Oxytocin contractpharma
September 15, 2020
Vectura Group plc has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences (MIPS), to develop inhaled oxytocin delivered via a dry powder inhaler to prevent postpartum hemorrhage (PPH) in childbirth.